RFI Partners with Ilhwa on Ginseng Technology
February 20, 2013
BLAUVELT, N.Y.RFI, a company focusing on formulations, products and solutions for the dietary supplement industry, has partnered with Ilhwa North America Inc., a nutraceutical company specializing in pharmaceuticals, ginseng and beverages. RFI and Ilhwa will be collaborating and researching for new discoveries in ginseng technology.
GS15-4®, a ginseng extract manufactured by Ilhwa, uses a patented high-yield, enzyme fermentation to produce a balanced extract in an end-stage metabolite form.
According to Ilhwa, the extract is clinically proven to provide 15 times higher absorption, four times faster absorption and four times more consistency.
RFI recently released its new FermaPro® line of fermented ingredients, including cereal grasses, vegetables, fruits, spices and seeds in January.
You May Also Like